Statistics Canada
www.statcan.gc.ca
Common menu bar links
Archived Content
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.
References
1. Tremblay M, Wolfson M, Connor Gorber S. Canadian Health Measures Survey: Rationale, background and overview. Health Reports (Statistics Canada, Catalogue 82-003) 2007; 18 (Suppl.): 7-20.
2. Mithal A, Wahl DA, Bonjour JP, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporosis International 2009. Aug 19 [Epub ahead of print].
3. Holick MF. Vitamin D deficiency. New England Journal of Medicine. 2007; 357(3): 266-81.
4. White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infectious Immunology 2008; 76: 3837-43.
5. Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington DC: National Academy Press, 1997.
6. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Archives of Internal Medicine 2009; 169(6): 551-61.
7. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. British Medical Journal 2009; 339: b3692 doi: 10.1136/bmj.b3692.
8. Lin J, Manson JE, Lee I-M, et al. Intakes of calcium and vitamin D and breast cancer risk in women. Archives of Internal Medicine 2007; 167(10): 1050-9.
9. Gorham ED, Garland CF, Garland FC, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. American Journal of Preventive Medicine 2007; 32: 210-6
10. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Archives of Internal Medicine 2008; 168: 1174-80.
11. Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLOS Genetics. 2009; 5(2): e1000369. Epub 2009 February 6.
12. Dixon T, Mitchell P, Beringer T, et al. An overview of the prevalence of 25-hydroxy-vitamin D inadequacy amongst elderly patients with or without fragility fracture in the United Kingdom. Current Medical Research and Opinion. 2006; 22: 405-15.
13. Ginde AT, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Archives of Internal Medicine 2009; 169(6): 626-32.
14. Mansbach JM, Ginde AA, Camargo CA. Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: do children need more vitamin D? Pediatrics 2009; 124: 1404-10.
15. Weiler HA, Leslie WD, Krahn J, et al. Canadian Aboriginal women have a higher rate of vitamin D deficiency than non-Aboriginal women status despite similar dietary vitamin D intakes. Journal of Nutrition 2007; 137: 461-5.
16. Gozdzik A, Barta JL, Wu C, et al. Low wintertime vitamin D levels in a sample of healthy young adults of diverse ancestry living in the Toronto area: Associations with vitamin D intake and skin pigmentation. BMC Public Health 2008 8: 336.
17. Roth DE, Prosser C, Martz P, et al. Are national guidelines sufficient to maintain adequate blood levels in children? Canadian Journal of Public Health 2005; 96: 443-9.
18. Rucker D, Allan JA., Fick GH, Hanley DA. Vitamin D insufficiency in a population of healthy western Canadians. Canadian Medical Association Journal 2002; 166: 1517-24.
19. Mark S, Gray-Donald K, Delvin EE, et al. Low vitamin D staus in a representative sample of youth from Quebec, Canada. Clinical Chemistry 2008; 54: 1283-9.
20. Vieth R, Cole DE, Hawker GA, et al. Wintertime vitamin D insufficiency is common in young Canadian women and their vitamin D intake does not prevent it. European Journal of Clinical Nutrition 2001; 55: 1091-7.
21. Weiler H, Fitzpatrick-Wong S, Veitch R, et al. Vitamin D deficiency and whole-body and femur bone mass relative to weight in healthy newborns. Canadian Medical Association Journal. 2005; 172(6): 757-61.
22. Newhook LA, Sloka S, Grant M, et al. Vitamin D insufficiency common in newborns, children and pregnant women living in Newfoundland and Labrador, Canada Maternal and Child Nutrition 2009; 5(2): 186-91.
23. Waiters B, Godel JC, Basu TK. Perinatal vitamin D and calcium status of northern Canadian mothers and their newborn infants. Journal of the AmericanCollege of Nutrition 1998; 18: 122-6.
24. Liu BA, Gordon M, Labranche JM, et al. Seasonal prevalence of vitamin D deficiency in institutionalized older adults. Journal of the American Geriatric Society 1997; 45: 598-603.
25. Giroux S. Canadian Health Measures Survey: Sampling strategy overview. Health Reports (Statistics Canada, Catalogue 82-003) 2007; 18 (Suppl.): 31-6.
26. Day B, Langlois R, Tremblay M, Knoppers B-M. Canadian Health Measures Survey: Ethical, legal and social issues. Health Reports (Statistics Canada, Catalogue 82-003) 2007; 18 (Suppl.): 37-51.
27. Bryan S, St-Denis M, Wojtas D. Canadian Health Measures Survey: Clinical operations and logistics. Health Reports (Statistics Canada, Catalogue 82-003) 2007; 18 (Suppl.): 53-70.
28. Statistics Canada. Canadian Health Measures Survey (CHMS) Data User Guide: Cycle 1. Available at: www.statcan.gc.ca.
29. Cole SR, Chu H, Nie L, Schisterman EF. Estimating the odds ratio when exposure has a limit of detection. International Journal of Epidemiology 2009; 38: 1674-80.
30. Yetley EA, Brule D, Cheney MC, et al., Dietary reference intakes for vitamin D: justification for a review of the 1997 values. American Journal of Clinical Nutrition 2009; 89: 719-27.
31. Vieth R, Bischoff-Ferrari H, Boucher BJ, et al. The urgent need to recommend an intake of vitamin D that is effective. American Journal of Clinical Nutrition 2007; 85: 649-50.
32. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. American Journal of Clinical Nutrition 2006; 84: 18-28.
33. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporosis International 2005; 16: 713-6
34. Hathcock JN, Shao A, Vieth R, Heaney RP. Risk assessment for vitamin D. American Journal of Clinical Nutrition 2007; 85: 6-18.
35. Jones G. Pharmacokinetics of vitamin D toxicity. American Journal of Clinical Nutrition 2008; 88: 582S-6S.
36. Looker AC, Pfeiffer CM, Lacher DA, et al. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. American Journal of Clinical Nutrition 2008; 88: 1519-27.
37. Webb AR, Engelsen O. Calculated ultraviolet exposure levels for a healthy vitamin D status. Photochemistry and Photobiology 2006; 82: 1697-703
38. Yetley EA. Assessing the vitamin D status of the US population. American Journal of Clinical Nutrition 2008; 88: 558S– 64S.
39. Looker AC, Dawson-Hughes B, Calvo MS, et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002; 30: 771-7.
40. Lips P, Bouillon R, van Schoor NM, et al. Reducing fracture risk with calcium and vitamin D. Clinical Endocrinology (Oxford) 2009 Sep 10. [Epub ahead of print]
41. IARC Working Group on Vitamin D. Vitamin D and Cancer (IARC Working Group Reports; 5) Lyon: International Agency for Research on Cancer, 2008. Available at: http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk5/Report_VitD.pdf. Accessed November 2, 2009.
